MASP-2 antibodies (NatImmune)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMASP-2 antibodies (NatImmune)
Drug Alias NameMASP inhibitors (NatImmune)mannan binding lectin-associated serine protease inhibitors (NatImmune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitors
TargetsMannan-binding lectin serine protease 2
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAzanta Danmark A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAzanta Danmark A/S
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A